With the continuous progress of modern medicine, cancer, the number one killer that threatens human life and health, has also made new breakthroughs with the joint efforts of global healthcare, and proton heavy ion therapy is one of them.

During the 2019 National Cancer Prevention and Control Promotion Week, the "China Youth Cancer Prevention Science Popularization Report" (hereinafter referred to as the "Report") was exclusively sponsored and supported by Zhongan Insurance. The report shows that cancer treatment has entered the era of multidisciplinary comprehensive treatment, with radiation therapy being the main method. 70% of tumor patients require radiation therapy at different stages, and proton heavy ion radiotherapy is currently the most cutting-edge tumor radiotherapy technology in the world. Therefore, proton heavy ion therapy will play an increasingly important role in the treatment of tumors.

Successful cancer treatment requires both tumor control and preservation of function. Based on this, proton heavy ion therapy has significant advantages over traditional cancer treatment. Proton heavy ion therapy can concentrate high doses on the tumor site that needs to be irradiated, while the dose of radiation to surrounding normal tissues is very low, which can effectively reduce radiation damage to important normal tissues. Meanwhile, proton heavy ion radiation can help improve tumor control and reduce radiation sequelae. On the other hand, heavy ions also have good biological effects, having a greater killing effect on pathological types that are not sensitive to conventional radiation, thereby significantly improving the control rate of such tumors.

Following the implementation of proton heavy ion therapy in the United States and Japan, China also invested in formal proton heavy ion radiotherapy institutions in 2014, and simultaneously put them into large-scale use. So far, there are approximately 120000 patients receiving proton therapy and approximately 20000 patients receiving carbon ion therapy worldwide.

Nowadays, although proton heavy ion therapy can alleviate patients' physical pain caused by long-term medication and more effectively treat cancer diseases, it is still an extremely cutting-edge medical technology, and its treatment cost is still a heavy burden for ordinary families.

Cancer has become a taboo term among modern people. Cancer is stronger than a tiger, and technological progress is undoubtedly good news for us. The improvement of medical scientific achievements is also conducive to the improvement of our health quotient. More and more people are realizing the importance of health quotient. Health quotient is not innate, but a new and scientifically based health concept built on the achievements and knowledge of medical science, A higher health quotient is a golden key to extending healthy lifespan. In fact, the prevention and treatment of cancer is also an important indicator of high or low health quotient. Cancer is closely related to genetics, age, lifestyle, and living environment, but genetic factors only account for 20%, while other factors related to living environment and lifestyle account for 80%. As long as we change our lifestyle, we can reduce the probability of cancer occurrence.

As the national medical insurance brand with the fastest iteration and upgrading, the widest connectivity services, and the most internet users in the current market, Zhong'an Insurance always pays attention to national medical insurance and national health. Our million dollar medical insurance product, Zunxiang eSheng, has undergone 12 unremitting efforts, upgrades, and iterations. Not only has it launched an optional proton heavy ion medical refueling package, but it can also provide personalized and high-quality value-added services such as medical treatment in Japan, new special drugs for tumors, and postoperative home care. Data shows that as of the end of 2017, the number of users of Zunxiang eSheng has exceeded 1 million, with an average age of 35 years old. Among them, 70% of the insured are under the age of 40, and the new generation born in the 1980s has become the main purchasing group, becoming the first choice for the new generation of internet insured when purchasing mid-range medical insurance.